986
Views
30
CrossRef citations to date
0
Altmetric
Articles

Anticancer potential of dietary vitamin D and ascorbic acid: A review

, &

References

  • Aggarwal, B. B. and Shishodia, S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochemical Pharmacology. 71:1397–421.
  • Alavi, S., Bugusu, B., Cramer, G., Dary, O., Lee, T., Martin, L., McEntire, J. and Wailes, E. (2008). Rice Fortification in Developing Countries: A Critical Review of the Technical and Economic Feasibility. Available from http://pdf.usaid.gov/pdf_docs/PNACD279.pdf
  • Anand, P., Kunnumakkara, A. B., Kunnumakara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., Sung, B. and Aggarwal, B. B. (2008). Cancer is a preventable disease that requires major lifestyle changes. Pharmaceutical Research. 25(9):2097–2116.
  • Azad, N., Iyer, A, Vallyathan, V., Wang, L., Castranova, V., Stehlik, C. and Rojanasakul, Y. (2010). Role of oxidative/nitrosative stressmediated Bcl2 regulation in apoptosis and malignant transformation. Annals of the New York Academy of Sciences. 1203:1–6.
  • Bao, B. Y., Hu, Y. C., Ting, H. J. and Lee, Y. F. (2004). Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells. Oncogene. 23:3350–3360.
  • Bao, B. Y., Ting, H. J., Hsu, J. W. and Lee, Y. F. (2008). Protective role of 1 alpha, 25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells. International Journal of Cancer. 122:2699–2706.
  • Bates, C. J. (1997). Bioavailability of vitamin C. European Journal of Clinical Nutrition. 51(Suppl 1):S28–33.
  • Baudet, C., Chevalier, G., Chassevent, A., Canova, C., Filmon, R., Larra, F., Brachet, P. and Wion, D. (1996). 1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line. Journal of Neuroscience Research. 46:540–550.
  • Bauer, S. R., Hankinson, S. E., Bertone-Johnson, E. R. and Ding, E. L. (2013). Plasma vitamin D levels, menopause, and risk of brast cancer: Dose–response meta-analysis of prospective studies. Medicine (Baltimore). 92(3):123–131.
  • Beaglehole, R., Bonita, R. and Magnusson, R. (2011). Global cancer prevention: An important pathway to global health and development. Public Health. 125:821–831.
  • Beetens, J. R. and Hermen, A. G. (1983). Ascorbic acid and Prostaglandin formation. International Journal for Vitamin and Nutrition Research. 24(Suppl):131s–44s.
  • Ben-Shoshan, M., Amir, S., Dang, D.T., Dang, L.H., Weisman, Y. and Mabjeesh, N.J. (2007). 1alpha,25- Dihydroxyvitamin D3 (calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Molecular Cancer Therapeutics. 6:1433–1439.
  • Bertone-Johnson, E. R. (2009). Vitamin D and breast cancer. Annals of Epidemiology. 19:462–467.
  • Bishayee, A., Haskell, Y., Do, C., Siveen, K. S., Mohandas, N., Sethi, G. and Stoner, G. D. (2015). Potential Benefits of Edible Berries in the Management of Aerodigestive and Gastrointestinal Tract Cancers: Preclinical and Clinical Evidence. Critical Reviews in Food Science and Nutrition. DOI: 10.1080/10408398.2014.982243.
  • Brenza, H. L. and DeLuca, H. F. (2000). Regulation of 25- hydroxyvitamin D3 1α-hydroxylase gene expression by parathyroid hormone and 1, 25-dihydroxyvitamin D3. Archives of Biochemistry and Biophysics. 381:143–152
  • Bruno, E. J. Jr, Ziegenfuss, T. N. and Landis, J. (2006). Vitamin C: Research update. Current Sports Medicine Reports. 5:177–81.
  • Burton, G. W., Wronska, U. and Stone, L. (1990). Biokinetics of dietary RRR-OC-tocopherol in the male guinea pig at three dietary levels of vitamin C does not spare vitamin E in vivo. Lipids. 25:199–210.
  • Calvo, M. S. and Whiting, S. J. (2013). Survey of current vitamin D food fortification practices in the United States and Canada. The Journal of Steroid Biochemistry and Molecular Biology. 136:211–213.
  • Calvo, M. S., Whiting, S. J. and Barton, C. N. (2004). Vitamin D fortification in the United States and Canada: Current status and data needs. The American Journal of Clinical Nutrition. 80:1710S–1716S.
  • Cameron, E. and Pauling, L. (1976). Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proceedings of National Academy of Sciences USA. 73:3685–3689.
  • Cameron, E. and Pauling, L. (1973). Ascorbic acid and the glycosaminoglycan: An orthomolecular approach to cancer and other diseases. Oncology. 27:181–92.
  • Cancer Fact sheet. World Health Organization (2014). Retrieved 10 June 2014.
  • Carr, A. C. and Frei, B. (1999). Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. The American Journal of Clinical Nutrition. 69:1086–1107.
  • Casciari, J. J., Riordan, N. H., Schmidt, T. L., Meng, X. L., Jackson, J. A. and Riordan, H. D. (2001). Cytotoxicity of ascorbate, lipoic acid and other antioxidants in hollow fiber in vitro tumours. British Journal of Cancer. 84:1544–50.
  • Cauley, J. A., Chlebowski, R. T., Wactawski-Wende, J., Robbins, J. A., Rodabough, R. J., Chen, Z., Johnson, K. C., O'sullivan, M. J., Jackson, R. D. and Manson, J. E. (2013). Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: The Women's Health Initiative. Journal of Women's Health. 22(11):915–929.
  • Chan, J. M., Pietinen, P., Virtanen, M., Malila, N., Tangrea, J., Albanes, D. and Virtamo, J. (2000). Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control. 11:859–867.
  • Chaudhary, N., Sunil Kumar, B. V., Bhardwaj, R. and Singh, T. (2014). Expression of erythroblastic leukemia viral oncogene homolog 2 (ERBB2) from canine mammary tumor. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences. DOI 10.1007/s40011-014-0455-z.
  • Chen, Q., Espey, M. G., Krishna, M. C., Mitchell, J. B., Corpe, C. P., Buettner, G. R., Shacter, E. and Levine, M. (2005). Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proceedings of National Academy of Sciences USA. 102(38):13604–13609.
  • Chen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L. and Krishna, M. C. (2008) Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proceedings of National Academy of Sciences USA. 105:11105–11109
  • Chen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L., Krishna, M. C., Khosh Jeanne Drisko, D. B. and Levine, M. (2008). Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proceedings of National Academy of Sciences USA. 105:11105–11109.
  • Chen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L., Krishna, M. C., Khosh, D. B., Drisko, J. and Levine, M. (2008). Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proceedings of National Academy of Sciences USA. 105(32):11105–11109.
  • Chlebowski, R. T., Johnson, K. C., Kooperberg, C., Pettinger, M., Wactawski-Wende, J., Rohan, T., Rossouw, J., Lane, D., O'sullivan, M. J., Yasmeen, S., Hiatt, R. A., Shikany, J. M., Vitolins, M., Khandekar, J., Hubbell, F. A. and Women's Health Initiative Investigators. (2008). Calcium plus vitamin D supplementation and the risk of breast cancer. Journal of National Cancer Institute. 100:1581–1591.
  • Conejo-Garcia, J. R., Benencia, F., Courreges, M. C., Mohamed-Hodley, A., Buckanovich, R. J., Holtz, D. O., Jenkins, A., Zhang, L. N. H., Wagner, D. S., Katsaros, D., Caroll, R. and Coukos, G. (2004). Tumor-infiltrating dendritic cells precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nature Medicine. 10:950–958.
  • De Zarn, T. J. (1995). Food ingredient encapsulation. In: Encapsulation and controlled release of food ingredients. American Chemical Society Symposium Series 590, pp. 113–131. Risch, S. J. and Reineccius, G. A., Ed., American Chemical Society, Washington, DC.
  • Deeb, K. K., Trump, D. L. and Johnson, C. S. (2007). Vitamin D signalling pathways in cancer: Potential for anticancer therapeutics. Nature Reviews Cancer. 7:684–700.
  • Di Domenico, F., Foppoli, C., Coccia, R. and Perluigi, M. (2012). Antioxidants in cervical cancer: Chemopreventive and chemotherapeutic effects of polyphenols. Biochimica et Biophysica Acta. 1822:737–747.
  • Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R. and Wright, N. A. (2004). Bone marrow contribution to tumor associated myofibroblasts and fibroblasts. Cancer Research. 64:8492–8495.
  • Du, J., Martin, S. M., Levine, M., Wagner, B. A., Buettner, G. R. and Wang, S. H. (2010) Mechanisms of ascorbate induced cytotoxicity In pancreatic cancer. Clinical Cancer Research. 16:509–20
  • Feldman, D., Skowronski, R. J. and Peehl, D. M. (1995). Vitamin D and prostate cancer. Advances in Experimental and Medical Biology. 375:53–63.
  • Fleet, J.C., DeSmet, M., Johnson, R. and Li, Y. (2012). Vitamin D and cancer: A review of molecular mechanisms. Biochemical Journal. 441:61–76.
  • Gandini, S., Boniol, M., Haukka, J., Byrnes, G., Cox, B., Sneyd, M.J., Mullie, P. and Autier, P. (2011). Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. International Journal of Cancer. 128(6):1414–1424.
  • Garavello, W., Lucenteforte, E., Bosetti, C. and La Vecchia, C. (2009). The role of foods and nutrients on oral and pharyngeal cancer risk. Minerva Stomatologica. 58:25–34.
  • Gilloteaux, J., Jamison, J. M., Arnold, D., Ervin, E., Echroat, L., Docherty, J. J., Neal, D. and Summers, J. L. (1998). Cancer cell necrosis by autoshizis: Synergism of antitumor activity of vitamin C: Vitamin K3 on human bladder carcinoma T-24 cells. Scanning. 20:564–75.
  • Gilloteaux, J., Jamison, J. M., Arnold, D., Taper, H. S. and Summers, J. L. (2001). Ultrastructural aspects of autoshizis: A new cancer cell death induced by the synergistic action of ascorbate/menadione on human bladder carcinoma cells. Ultrastructural Pathology. 25:183–92.
  • Goetzl, E. J., Wasserman, S. I., Gigli, I. and Austen, K. F. (1974). Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. Journal of Clinical Investigation. 53:813–8.
  • Gonzalez, M.J. (1992). Lipid peroxidation and tumor growth: An inverse relationship. Medical Hypotheses. 38:106–10.
  • Gonzalez, M. J., Mora, E., Riordan, N. H., Riordan, H. D. and Mojica, P. (1998). Rethinking vitamin C and cancer: An update on nutritional oncology. Cancer Prevention International. 3:215–24.
  • Goodwin, P. J., Ennis, M., Pritchard, K. I., Koo, J. and Hood, N. (2009). Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. Journal of Clinical Oncology. 27:3757–3763.
  • Grad, J. M., Bahlis, N. J., Reis, I., Oshiro, M. M., Dalton, W. S. and Boise, L. H. (2001). Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood. 98:805–13.
  • Gregory, J. F. 3rd. (1993). Ascorbic acid bioavailability in foods and supplements. Nutrition Reviews. 51:301–303.
  • Guerriero, E., Sorice, A., Capone, F., Napolitano, V., Colonna, G., Storti, G., Castello, G. and Costantini1, S. (2014). Vitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell lines. PLOS One. DOI:10.1371/journal.pone.0115287
  • Gutteridge, J. M. C., Richmond, R. and Halliwell, B. (1980). Oxygen free-radicals and lipid peroxidation: Inhibition by the protein caeruloplasmin. FEBS Letters. 112:269–72.
  • Harris, H. R., Orsini, N. and Wolk, A. (2014). Vitamin C and survival among women with breast cancer: A meta-analysis. European Journal of Cancer. 50:1223–1231.
  • Hecht, S. S. (1997). Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis. Proceedings of the Society for Experimental Biology and Medicine. 216:181–191.
  • Hoffer, L. J., Levine, M., Assouline, S., Melnychuk, D., Padayatty, S. J., Rosadiuk, K., Rousseau, C., Robitaille, L. and Miller, W.H. Jr. (2008). Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Annals of Oncology. 19:1969–1974.
  • Holly, R., Orsini, H. N. and Wolk, A. (2014). Vitamin C and survival among women with breast cancer: A Meta-analysis. European Journal of Cancer. 50:1223–1231.
  • Hu, M. L. (2011). Dietary polyphenols as antioxidants and anticancer agents: More questions than answers. Chang Gung Medical Journal. 34:449–460.
  • Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross, A. C., Taylor, C. L. and Yaktine, A. L. et al., editors. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011. Available from http://www.ncbi.nlm.nih.gov/books/NBK56070/
  • Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000. Nutrition and Physical Activity Guidelines Advisory Committee. (2012). American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA: A Cancer Journal for Clinicians. 62:30-67.
  • Iqbal, M. U. N., Khan, T. A. and Maqbool, S. A. (2015). Vitamin D Receptor Cdx-2 Polymorphism and Premenopausal Breast Cancer Risk in Southern Pakistani Patients. PLoS One. 10(3):e0122657. doi:10.1371/journal.pone.0122657.
  • Jacob, R. A. and Sotoudeh, G. (2002). Vitamin C function and status in chronic disease. Nutrition in Clinical Care. 5:66–74.
  • Jensen, S. S., Madsen, M. W., Lukas, J., Binderup, L. and Bartek, J. (2001). Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Molecular Endocrinology. 15:1370–1380.
  • Jonas, S. K., Riley, P. A. and Willson, R. L. (1989). Hydrogen peroxide cytotoxicity. Biochemical Journal. 264:651–655.
  • Kennedy, J. F. (1976). Chemical and biochemical aspects of the glycosaminoglycans and proteoglycans in health and disease. Advances in Clinical Chemistry. 18:1–101.
  • Kim, J. E., Kang, J. S., Jung, D. J., Hahm, E., Lee, S. K., Bae, S. Y., Hwang, Y., Shin, D. H. and Lee, W. J. (2007). Vitamin C induces apoptosis in human colon cancer cells through endoplasmic reticulum stress and mitochondrial pathway. The Journal of Immunology. 178:(1 Supplement): S87–S88.
  • Konety, B. R. and Getzenberg, R. H. (2002). Vitamin D and prostate cancer. Urologic Clinics of North America. 29:95–106.
  • Krishnan, A. V., Peehl, D. M. and Feldman, D. (2005). In: Vitamin D and Prostate Cancer, Vitamin D, pp. 1679–1707. Feldman, D., Pike, J.W. and Glorieux, F., Eds., Academic Press, San Diego.
  • Kushi, L. H., Doyle, C., McCullough, M., Rock, C. L., Demark-Wahnefried, W., Bandera, E. V., Gapstur, S., Patel, A. V., Andrews, K., Gansler, T. and American Cancer Society (2010). Nutrition and Physical Activity Guidelines Advisory Committee. (2012). American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA: A Cancer Journal for Clinicians. 62:30–67.
  • Kwan, H. Y., Chao, X., Su, T., Fu, X., Wing Tse, A. K., Fong, W. F. and Yu, Z. L. (2015). The Anti-cancer and Anti-obesity Effects of Mediterranean Diet. Critical Reviews in Food Science and Nutrition. DOI: 10.1080/10408398.2013.852510.
  • Kyle, J. A., Sharp, L., Little, J., Duthie, G. G. and McNeill, G. (2010). Dietary flavonoid intake and colorectal cancer: A case–control study. British Journal of Nutrition. 103:429–436.
  • Leung, P. Y., Miyashita, K., Young, M. and Tsao, C. S. (1993). Cytotoxic effect of ascorbate and its derivative on cultured malignant and nonmalignant cell lines. Anticancer Research. 13:47–80.
  • Li, P., Li, C., Zhao, X., Zhang, X., Nicosia, S. V. and Bai, W. (2004). p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase. The Journal of Biological Chemistry. 279:25260–25267.
  • Li, Y. and Schellhorn, H. E. (2007). New developments and novel therapeutic perspectives for vitamin C. Journal of Nutrition. 137:2171–2184.
  • Lim, S. T., Jeon, Y. W. and Suh, Y. J. (2015). Association between alterations in the serum 25-hydroxyvitamin d status during follow-up and breast cancer patient prognosis. Asian Pacific Journal of Cancer Prevention. 16(6):2507–2513.
  • Loker, G. B., Ugur, M. and Yildiz, M. (2003). A partial supplementation of pasteurized milk with vitamin C, iron and zinc. Nahrung. 47(1):17–20.
  • Lopes, N., Sousa, B., Martins, D., Gomes, M., Vieira, D., Veronese. L. A., Milanezi, F., Paredes, J., Costa, J. L. and Schmitt, F. (2010). Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: A study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions. BMC Cancer. 10:483.
  • Losso, J. N. and Bawadi, H. A. (2005). Hypoxia inducible factor pathways as targets for functional foods. Journal of Agricultural and Food Chemistry. 53:3751–3768.
  • Lu, Z., Chen, T. C., Zhang, A., Persons, K. S., Kohn, N., Berkowitz, R., Martinello, S. and Holick, M. F. (2007). An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? The Journal of Steroid Biochemistry and Molecular Biology. 103:642–644.
  • Ma, Y., Zhang, P., Wang, F., Yang, J., Liu, Z. and Qin, H. (2011). Association between vitamin D and risk of colorectal cancer: A systematic review of prospective studies. Journal of Clinical Oncology. 29(28):3775–3782.
  • Madsen, K. H., Rasmussen, L. B., Andersen, R., Molgaard, C., Jakobsen, J., Bjerrum, P. J., Andersen, E. W., Mejborn, H. and Tetens, I. (2013). Randomized controlled trial of the effects of Vitamin D-fortified milk and bread on serum 25-hydroxy vitamin D concentrations in families in Denmark during winter: The vitmad study. The American Journal of Clinical Nutrition. 98:374–382.
  • Matsumoto, Y., Kittaka, A. and Chen, T. C. (2015). 19-Norvitamin D analogs for breast cancer therapy. Canadian Journal of Physiology and Pharmacology. 6:1–16.
  • Meyer, M. B., Goetsch, P. D. and Pike, J. W. (2012). VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: Impact on c-FOS and c-MYC gene expression. Molecular Endocrinology. 26:37–51.
  • Mikirova, N. A., Ichim, T. E. and Riordan, N. H. (2008). Anti-angiogenic effect of high doses of ascorbic acid. Journal of Translational Medicine. 6:50–58.
  • Miller, G. J. (1998). Vitamin D and prostate cancer: Biologic interactions and clinical potentials, Cancer Metastasis Reviews. 17:353–360.
  • Mocanu, V., Stitt, P..A., Costan, A..R., Voroniuc, O., Zbranca, E., Luca, V. and Vieth, R. (2009). Long-term effects of giving nursing home residents bread fortified with 125 μg (5000 IU) vitamin D3 per daily serving. The American Journal of Clinical Nutrition. 89:1132–1137.
  • Moreno, J., Krishnan, A. V. and Feldman, D. (2005). Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer. Journal of Steroid Biochemistry & Molecular Biology. 97:31–36.
  • Munoz, E., Blazquez, M. V., Ortiz, C., Gomez-Diaz, C. and Navas, P. (1997). Role of ascorbate in the activation of NF-κB by tumour necrosis factor-α in T-cells. Biochemical Journal. 325:23–8.
  • Natri, A. M., Salo, P., Vikstedt, T., Palssa, A., Huttunen, M., Karkkainen, M. U., Salovaara, H., Piironen, V., Jakobsen, J. and Lamberg-Allardt, C. J. (2006). Bread fortified with cholecalciferol increases the serum 25-hydroxyvitamin D concentration in women as effectively as a cholecalciferol supplement. Journal of Nutrition. 136:123–127.
  • Niki, E. (1991). Action of ascorbic acid as a scavenger of active and stable oxygen radicals. The American Journal of Clinical Nutrition. 54:1119s–24s.
  • Norman, A. W. (1998) Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: Integral components of the vitamin D endocrine system. The American Journal of Clinical Nutrition. 67:1108–1110.
  • Otten, J. J., Hellwig, J. P. and Meyers, L. D. (2006). Vitamin D. In: Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. National Academies Press, Washington, DC.
  • Padayatty, S. J., Katz, A., Wang, Y., Eck, P., Kwon, O., Lee, J. H., Chen, S., Corpe, C., Dutta, A., Dutta, S. K. and Levine, M. (2003). Vitamin C as an antioxidant: Evaluation of its role in disease prevention. The Journal of the American College of Nutrition. 22(1):18–35.
  • Padayatty, S. J. and Levine, M. (2006). Vitamins C and E and the prevention of preeclampsia. The New England Journal of Medicine. 355:1065.
  • Padayatty, S. J., Sun, H., Wang, Y., Riordan, H. D., Hewitt, S. M., Katz, A., Wesley, R. A. and Levine, M. (2004). Vitamin C pharmacokinetics: Implications for oral and intravenous use. Annals of Internal Medicine. 140:533–537.
  • Parise, R. A., Egorin, M. J., Kanterewicz, B., Taimi, M., Petkovich, M., Lew, A. M., Chuang, S. S., Nichols, M. M., El-Hefnawy, T. and Hershberger, P. A. (2006). CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer. International Journal of Cancer. 119:1819–1828.
  • Park, H., Seib, P. A. and Chung, O. K. (1994). Stabilities of several forms of vitamin C during making and storing of pup-loaves of white pan bread. Cereal Chemistry. 71(5):412–417.
  • Peehl, D. M., Seto, E., Hsu, J. Y. and Feldman, D. (2002). Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells. Journal of Urology. 168:1583–1588.
  • Pelucchi, C., Bosetti, C., Rossi, M., Negri, E., La Vecchia, C. (2009). Selected aspects of Mediterranean diet and cancer risk. Nutrition and Cancer. 61:756–766.
  • Peyman, G. A., Kivilcim, M., Dellacroce, J. T. and Munoz Morales, A. (2007). Inhibition of Corneal Neovascularization by Ascorbic Acid in Rat Model [abstract]. Graefe's Archive for Clinical and Experimental Ophthalmology. 245(10):1461–1467.
  • Pfeffer, F., Casanueva, E., Kamar, J., Guerra, A., Perichart, O. and Vadillo-Ortega, F. (1998). Modulation of 72-kilodalton type IV collagenase (Matrix metalloproteinase-2) by ascorbic acid in cultured human amnion-derived cells. Biology of Reproduction. 52:326.
  • Powers, H. J., Gibson, A. T., Bates, C. J., Primhak, R. A. and Beresford, J. (1994). Does vitamin C intake influence the rate of tyrosine catabolism in premature babies? Annals of Nutrition and Metabolism. 38:166–173.
  • Pulito, C., Terrenato, I., Di Benedetto, A., Korita, E., Goeman, F., Sacconi, A., Biagioni, F., Blandino, G., Strano, S., Muti, P., Mottolese, M. and Falvo, E. (2015). Cdx2 Polymorphism Affects the Activities of Vitamin D Receptor in Human Breast Cancer Cell Lines and Human Breast Carcinomas. PLoS One. 10(4):e0124894. doi:10.1371/journal.pone.0124894.
  • Riordan, N. H., Riordan, H. D. and Casciari, J. J. (2000). Clinical and experimental experiences with intravenous vitamin C. The Journal of Orthomolecular Medicine. 15:201–13.
  • Riordan, N. H., Riordan, H. D., Meng, X. L., Li, Y. and Jackson, J. A. (1995). Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Medical Hypotheses. 44:207–13.
  • Ritu, G. and Gupta, A. (2014). Vitamin D deficiency in india: Prevalence, causalities and interventions. Nutrients. 6:729–775.
  • Rose, A. A. N., Elser, C. and Ennis, M. (2013). Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis. Breast Cancer Research and Treatment. 141:331–339.
  • Salehi-Tabar, R., Nguyen-Yamamoto, L., Tavera-Mendoza, L. E., Quail, T., Dimitrov, V., An, B. S., Glass, L., Goltzman, D. and White, J. H. (2012). Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. Proceedings of National Academy of Sciences USA. 109:18827–18832.
  • Sasco, A. J., Secretan, M. B. and Straif, K. (2004). Tobacco smoking and cancer: A brief review of recent epidemiological evidence. Lung cancer. 45:S3–9.
  • Scatena, R. (2012). Mitochondria and cancer: A growing role in apoptosis, cancer cell metabolism and dedifferentiation. Advances in Experimental Medicine and Biology. 942:287–308.
  • Schwartz, G. G., Whitlatch, L. W., Chen, T. C., Lokeshwar, B. L. and Holick, M. F. (1998). Human prostate cells synthesize 1, 25-dihydroxyvitamin D3 from 25- hydroxyvitamin D3. Cancer Epidemiology, Biomarkers and Prevention. 7:391–395.
  • Sharma, R. (2005). Fortification of milk with microencapsulated vitamin C and its thermal stability. Journal of Food Science and Technology. 42(2):191–194.
  • Siegel, B.V. (1975). Enhancement of interferon production by poly (r1), poly (rC) in mouse cell cultures by ascorbic acid. Nature. 254:531–532.
  • Steele, C. (1976). Cereal fortification: Technological problems. Cereal Foods World. 21:538–540.
  • Stephen, R. and Utecht, T. (2001). Scurvy identified in the emergency department: A case report. The Journal of Emergency Medicine. 21:235–237.
  • Sunil Kumar, B. V. and Kataria, M. (2013). Identification of single nucleotide polymorphism in stromelysin-3 catalytic domain in canine mammary tumors. Journal of Applied Animal Research. 41(3):366–369.
  • Sunil Kumar, B. V., Kumar, K. A., Padmanath, K., Saxena, M., Sharma, B. and Kataria, M. (2013a). Development of Recombinant Matrix Metalloproteinase-11 Based Sandwich ELISA for the Diagnosis of Canine Mammary Tumor. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences. 83(2):181–185.
  • Sunil Kumar, B. V., Kumar, K. A., Padmanath, K., Sharma, B. and Kataria, M. (2013b). Heterologous Expression and Functional Characterization of Matrix Metalloproteinase-11 from Canine Mammary Tumor. Animal Biotechnology. 24(1):31–43.
  • Sunil Kumar, B. V., Singh, G. and Meur, S. K. (2010). Effects of addition of electrolyte and ascorbic acid in feed during heat stress in buffaloes. Asian Australasian Journal of Animal Sciences. 23(7):880–888.
  • Tang, C., Chen, N., Wu, M., Yuan, H. and Du, Y. (2009). Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: A meta-analysis. Breast Cancer Research and Treatment. 117:391–399.
  • Taylor, P. R., Li, B., Dawsey, S. M., Li, J. Y., Yang, C. S., Guo, W. and Blot, W. J. (1994). Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group. Cancer Research. 54(7S):2029s-2031s.
  • Tomiska, M., Novotna, S., Klvacova, L., Tumova, J. and Janikova, A. (2015). Vitamin D during cancer treatment. Klinická onkologie. 28(2):99–104.
  • Townsend, K., Banwell, C. M., Guy, M., Colston, K.W., Mansi, J. L., Stewart, P. M., Campbell, M. J. and Hewison, M. (2005). Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clinical Cancer Research. 11:3579–86.
  • Tsao, C. S., Dunhan, W. B. and Leung, P. Y. (1988). In vivo antineoplastic activity of ascorbic acid for human mammary tumor. In vivo. 2:147–50.
  • Tsao, C. S., Dunhan, W. B. and Leung, P. Y. (1989). Effect of ascorbic acid and its derivatives on the growth of human mammary tumor xenografts in mice. The Cancer Journal. 5:53–9.
  • U.S. Department of Agriculture, Agricultural Research Service. 2011. USDA National Nutrient Database for Standard Reference, Release 24. Nutrient Data Laboratory Home Page, http://www.ars.usda.gov/ba/bhnrc/ndl.
  • Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M. and Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology. 39:44–84.
  • Vandenberg, J. J., Kuypers, F. A., Roelofsen, B. and Op den Kamp, J. A. (1990). The cooperative action of vitamins E and C in the protection against peroxidation of parinanic acid in human erythrocyte menbranes. Chemistry and Physics of Lipids. 53:309–20.
  • Verrax, J., Delvaux, M., Beghein, N., Taper, H., Gallez, B. and Buc Calderon, P. (2005). Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study. Free Radical Research. 39(6):649–657.
  • Visioli, F., Bogani, P., Grande, S., and Galli, C. (2005). Mediterranean food and health: Building human evidence. Journal of Physiology and Pharmacology. 56(S1):37–49.
  • Wang, A. H. and Still, C. (2007). Old world meets modern: A case report of scurvy. Nutrition in Clinical Practice. 22:445–448.
  • Wang, D., Velez de-la-Paz, O. I., Zhai, J. X. and Liu, D. W. (2013). Serum 25-hydroxyvitamin D and breast cancer risk: A meta-analysis of prospective studies. Tumor Biology. 34(6):3509–3517.
  • Washington, M. N., Kim, J. S. and Weigel, N. L. (2011). 1α,25-dihydroxyvitamin D3 inhibits C4–2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrest. The Prostate. 71:98–110.
  • Weinstein, M., Babyn, P. and Zlotkin, S. (2001). An orange a day keeps the doctor away: Scurvy in the year 2000. Pediatrics. 108(3):E55.
  • World Cancer Report (2014). World Health Organization. pp. Chapter 1.1. ISBN 9283204298.
  • Wyllie, A. H. (1987). Apoptosis: Cell death in tissue regulation. The Journal of Pathology. 153:313–316.
  • Xu, Y., Shibata, A., McNeal, J. E., Stamey, T. A., Feldman, D. and Peehl, D. M. (2003). Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression. Cancer Epidemiology, Biomarkers and Prevention. 12:23–27.
  • Yamamoto, K., Takahashi, M. and Niki, E. (1987). Role of iron and ascorbic acid in the oxidation of methyl linoleate micelles. Chemistry Letters. 1:49–52.
  • Yang, Z., Laillou, A., Smith, G., Schofield, D. and Moench-Pfanner, R. (2013). A review of vitamin D fortification: Implications for nutrition programming in southeast Asia. Food and Nutrition Bulletin. 34:S81–S89.
  • Zehnder, D., Bland, R., Williams, M. C., McNinch, R. W., Howie, A. J., Stewart. P. M. and Hewison, M. (2001). Extrarenal expression of 25-hydroxyvitamin d(3)1 α-hydroxylase. The Journal of Clinical Endocrinology and Metabolism. 86:888–894.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.